Covid-19: US approval for Moderna teen vaccines delayed

The evaluation on whether to recommend Moderna’s vaccine for 12- to 17-year-olds could last until January 2022

Related Keywords

United States ,American ,Moderna Covid ,Pfizer ,Us Centers For Disease ,Drug Administration ,Reuters ,Disease Control ,Covid 19 Vaccine ,Moderna Vaccination ,Fda ,Sa ,